NUVATION BIO INC's ticker is NUVB and the CUSIP is 67080N101. A total of 130 filers reported holding NUVATION BIO INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,740,922 | +2.9% | 19,209,643 | +38.2% | 0.87% | +41.6% |
| Q2 2023 | $25,013,777 | +8.4% | 13,896,543 | 0.0% | 0.61% | -17.5% |
| Q1 2023 | $23,068,261 | -13.5% | 13,896,543 | 0.0% | 0.74% | -8.5% |
| Q4 2022 | $26,681,363 | -14.3% | 13,896,543 | 0.0% | 0.81% | -11.6% |
| Q3 2022 | $31,128,000 | -30.9% | 13,896,543 | 0.0% | 0.92% | -40.9% |
| Q2 2022 | $45,025,000 | -38.4% | 13,896,543 | 0.0% | 1.55% | -32.1% |
| Q1 2022 | $73,096,000 | -38.1% | 13,896,543 | 0.0% | 2.29% | -39.2% |
| Q4 2021 | $118,121,000 | -13.3% | 13,896,543 | +1.3% | 3.76% | -20.6% |
| Q3 2021 | $136,292,000 | +6.8% | 13,711,517 | 0.0% | 4.74% | -0.6% |
| Q2 2021 | $127,654,000 | -7.8% | 13,711,517 | +3.5% | 4.77% | -22.3% |
| Q1 2021 | $138,431,000 | – | 13,247,017 | – | 6.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 22,957,340 | $120,756,000 | 24.71% |
| Aisling Capital Management LP | 2,541,009 | $13,366,000 | 7.21% |
| EDBI Pte Ltd | 1,270,504 | $6,683,000 | 4.45% |
| Ally Bridge Group (NY) LLC | 1,137,152 | $5,981,000 | 4.43% |
| EcoR1 Capital, LLC | 13,896,543 | $73,096,000 | 2.29% |
| Boxer Capital, LLC | 4,341,009 | $22,834,000 | 1.17% |
| Baupost Group | 10,443,494 | $54,933,000 | 0.59% |
| Redmile Group, LLC | 3,471,709 | $18,261,000 | 0.57% |
| Avidity Partners Management LP | 4,855,006 | $25,537,000 | 0.53% |
| Abrams Capital Management | 3,811,513 | $20,049,000 | 0.47% |